NCT05341921

Brief Summary

Slow deep breathing actives the vagal nerve and leads to a natural reduction in physiological parameters such as blood pressure, heart rate and digestion. The effects of these techniques have not been assessed in pregnancy. The primary objective is to assess the effects of various yogic deep breathing techniques on blood pressure during pregnancy. The breathing exercises will include Alternate nostril breathing, Bhramari breathing, and Sheetali breathing. A secondary objective will be to assess the effects of these breathing exercises on other physiological parameters including heart rate, heart rate variability, body temperature, cardiac output, vascular resistance and respiratory rate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 22, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

August 2, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 20, 2025

Status Verified

April 1, 2025

Enrollment Period

2.4 years

First QC Date

April 18, 2022

Last Update Submit

April 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of blood pressure from baseline in normotensive and hypertensive women in 3rd trimester pregnancy while utilizing various pranayama breathing techniques

    Continuous blood pressure monitored while participants engage in a deep breathing technique (pranayama breathing)

    One visit, 15 minute intervention

Secondary Outcomes (3)

  • Change of heart rate from baseline to after the intervention

    One visit, 15 minute intervention

  • Change in body temperature from baseline to after the intervention

    One visit, 15 minute intervention

  • Change in cardiac output from baseline to after the intervention

    One visit, 15 minute intervention

Study Arms (6)

Alternate Nostril Breathing Phase I

ACTIVE COMPARATOR

Alternate nostril breathing for normotensive women in 3rd trimester of pregnancy

Behavioral: Alternate Nostril Breathing

Bhramari Breathing Phase I

ACTIVE COMPARATOR

Bhramari breathing for normotensive women in 3rd trimester of pregnancy

Behavioral: Bhramari Breathing

Sheetali Breathing Phase I

ACTIVE COMPARATOR

Sheetali breathing for normotensive women in 3rd trimester of pregnancy

Behavioral: Sheetali Breathing

Alternate Nostril Breathing Phase II

ACTIVE COMPARATOR

Alternate nostril breathing for hypertensive women in 3rd trimester of pregnancy

Behavioral: Alternate Nostril Breathing

Bhramari Breathing Phase II

ACTIVE COMPARATOR

Bhramari breathing for hypertensive women in 3rd trimester of pregnancy

Behavioral: Bhramari Breathing

Sheetali Breathing Phase II

ACTIVE COMPARATOR

Sheetali breathing for hypertensive women in 3rd trimester of pregnancy

Behavioral: Sheetali Breathing

Interventions

Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Alternate Nostril Breathing Phase IAlternate Nostril Breathing Phase II

Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Bhramari Breathing Phase IBhramari Breathing Phase II

Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Sheetali Breathing Phase ISheetali Breathing Phase II

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Any pregnant woman in the 3rd trimester after 28 weeks of pregnancy who is/has
  • years of age or older
  • English speaking
  • Phase II Only- Chronic hypertension - defined as pre-existing elevated blood pressure prior to pregnancy or less than 20 weeks gestation (Systolic blood pressure greater than or equal to 140 mmHg and /or a diastolic blood pressure greater than or equal to 90 mmHg) with or without antihypertensive use
  • Phase II Only- Gestational hypertension - defined as elevated blood pressure (Systolic blood pressure greater than or equal to 140 mmHg and /or a diastolic blood pressure greater than or equal to 90 mmHg) after 20 weeks of pregnancy without any evidence of end-organ damage or proteinuria, with or without antihypertensive use
  • Phase II Only- Preeclampsia without severe features - defined as elevated blood pressure (Systolic blood pressure greater than or equal to 140 mmHg but less than 160 mmHG and /or a diastolic blood pressure greater than or equal to 90 mmHg but less than 110 mmHg on two or more occasions 4 hours or more apart) with evidence of proteinuria, with or without antihypertensive use

You may not qualify if:

  • Any unstable maternal or fetal condition that requires urgent delivery
  • Any concerns for pre-eclampsia with or without severe features (i.e. Development of HELLP syndrome or eclampsia)
  • Severe pulmonary disease
  • Active or acute pulmonary disease
  • Known deviated nasal septum
  • Does not desire to perform breath-controlled exercises
  • Low blood pressure defined as baseline blood pressure less or equal to a systolic of 90 mmHg and/or a diastolic blood pressure of 60 mmHg
  • Cannot roll their tongue
  • Have difficulty or cannot breathe through their nose

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Advent Health Shawnee Mission Birth Center

Merriam, Kansas, 66204, United States

Location

MeSH Terms

Conditions

Hypertension, Pregnancy-Induced

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Shilpa Babbar, MD

    Children's Mercy Hospital Kansas City

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Pilot, randomized, controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 18, 2022

First Posted

April 22, 2022

Study Start

August 2, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 20, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations